The Patent Asset Index - A new approach to benchmark patent portfolios

World Patent Information

Volumn 33, Issue 1, 2011, Pages 34-41

  Ernst, Holger ^a   Omland, Nils ^b  

^a WHU OTTO BEISHEIM SCHOOL OF MANAGEMENT   (Germany)

^b PatentSight GmbH   (Germany)

Author keywords

Asset; Benchmarking; Innovation; Patent; Patent Asset Index; Portfolio; Ranking; Research Development; Scoreboard; Technology; Valuation

Indexed keywords

EID: 78751703103     PISSN: 01722190     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.wpi.2010.08.008     Document Type: Article

References (52)

1. Arundel A., Kabla I. What percentage of innovations is patented? Empirical estimates for European firms. Res Policy 1998, 27:127-141.
2. Brouwer E., Kleinknecht A. Innovative output and a firm's propensity to patent. An exploration of CIS micro data. Res Policy 1999, 28:615-624.
3. Mansfield E. How rapidly does new industrial technology leak out?. J Indust Econ 1985, 34(2):217-223.
4. Scherer F.M. The propensity to patent. Int J Indust Organiz 1983, 1:107-128.
5. Ernst H. Patent portfolios for strategic R&D planning. J Eng Technol Manage 1998, 15(4):279-308.
6. Ernst H. Patent information for strategic technology management. World Patent Inform 2003;25(3):233-42.
7. Fabry B., Ernst H., Langholz J., Köster M. Patent portfolio analysis as a useful tool for identifying business opportunities - an empirical application in the nutrition and health industry. World Patent Inform 2006, 28(3):215-225.
8. Dou H. Benchmarking R&D and companies through patent analysis using free databases and special software: a tool to improve innovative thinking. World Patent Inform 2004, 26(4):297-309.
9. Ernst H. Patent applications and subsequent changes of performance: evidence from time-series cross-section analyses on the firm level. Res Policy 2001, 30(1):143-157.
10. DuPont. Annual report; 2007.
11. DuPont. The Patent Board and Nature Biotechnology rank DuPont no. 1 innovator in the chemical industry and no. 1 in biotech patents. Press release by DuPont published March 12, 2008. Available online at: <>. http://onlinepressroom.net/DuPont/NewsReleases.
12. Halliburton Company Q2 2008 Earnings Call. Transcript available online at <>. http://seekingalpha.com/article/86280-halliburton-company-q2-2008-earnings-call-transcript.
13. Criscuolo P. The 'home advantage' effect and patent families. A comparison of OECD triadic patents, the USPTO and the EPO. Scientometrics 2006, 66(1):23-41.
14. Zuniga P, Guellec D, Dernis H, Khan M, Okazaki T, Webb C. OECD patent statistics manual. Paris: OECD Publications; 2009.
15. Gambardella A., Harhoff D., Verspagen B. The value of European patents. European Management Review 2008, 5:69-84.
16. Harhoff D., Scherer F.M., Vopel K. Citations, family size, opposition and the value of patent rights. Res Policy 2003, 32(8):1343-1363.
17. Pakes A. Patents as options: some estimates of the value of holding European patent stocks. Econometrica 1986, 54(4):755-784.
18. Schankerman M. How valuable is patent protection? Estimates by technology field. RAND J Econ 1998, 29(1):77-107.
19. Barney J. A study of patent mortality rates: using statistical analysis to rate and value patent assets. AIPLA Quart J 2002, 30(3):317-353.
20. Höfer T., Przyrembel H. New evidence for the theory of the stork. Paediat Perinat Epidemiol 2004, 18(1):88-92.
21. Carpenter M.P., Narin F., Woolf P. Citation rates to technologically important patents. World Patent Inform 1981, 3(4):160-163.
22. Albert M.B., Avery D., Narin F., McAllister P. Direct validation of citation counts as indicators of industrially important patents. Res Policy 1991, 20:251-259.
23. Hall B.H., Jaffe A., Trajtenberg M. Market value and patent citations. RAND J Econ 2005, 36(1):16-38.
24. Jaffe A.B., Schankerman M. Patents, citations & innovations: a window on the knowledge economy 2002, MIT Press, Cambridge.
25. Shane S. Technological opportunities and new firm creation. Manage Sci 2001, 47(2):205-220.
26. Trajtenberg M. A penny for your quotes: patent citations and the value of innovations. RAND J Econ 1990, 21(1):172-187.
27. The Wall Street Journal, 26 February 2008.
28. Deng Z., Lev B., Narin F. Science & technology as predictors of stock performance. Financ Anal J 1999, 55(3):20-32.
29. PatentSight worldwide patent intelligence database.
30. World Bank. World Development indicators database; 15 September 2009. Available online at: <>. http://siteresources.worldbank.org/DATASTATISTICS/Resources/GNI.pdf.
31. Bregonje M. Patents: a unique source for scientific technical information in chemistry related industry?. World Patent Inform 2005, 27(4):309-315.
32. Stevnsborg N, van Pottelsberghe B. Patenting procedures and filing strategies at the EPO. In: Guellec D, van Pottelsberghe B, editors. The economics of the European patent system. Oxford Scholarship Online Monographs; 2007. p. 155-84.
33. Sipapin Y.V., Kolesnikov A.P. Patent equivalents: problems of retrieval and patent family term tracing in databases. World Patent Inform 1989, 11(3):139-146.
34. Magerman T, van Looy B, Song X. Data production methods for harmonized patent indicators: patentee name harmonization. Eurostat working paper and studies. Luxembourg: Office for Official Publications of the European Communities; 2006.
35. Thoma G, Torrisi S, Gambardella A, Guellec D, Hall BH, Harhoff D. Harmonising and combining large datasets - an application to firm-level patent and accounting data. NBER working paper series, vol. w15851; 2010. Available at SSRN: <>. http://ssrn.com/abstract=1578688.
36. Ernst H., Soll J.H. An integrated portfolio approach to support market-oriented R&D planning. Int J Technol Manage 2003, 26(5/6):540-560.
37. Harhoff D., Hoisl K. Institutionalized incentives for ingenuity - patent value and the German Employees' Inventions Act. Res Policy 2007, 36(8):1143-1162.
38. Lanjouw J.O., Schankerman M. Patent quality and research productivity: measuring innovation with multiple indicators. Econ J 2004, 114(495):441-465.
39. Ernst H. Patentinformationen für die strategische Planung von Forschung und Entwicklung 1996, DUV, Wiesbaden.
40. Lanjouw J.O., Pakes A., Putnam J. How to count patents and value intellectual property: the uses of patent renewal and application data. J Indust Econ 1998, XLVI(4):405-431.
41. Putnam J. The value of international patent rights. New Haven: Yale University Press; 1996.
42. Reitzig M. Improving patent valuations for management purposes: validating new indicators by analyzing application rationales. Res Policy 2004, 33(6/7):939-957.
43. Harhoff D., Wagner S. Modelling the duration of patent examination at the European Patent Office. Manage Sci 2009, 55(12):1969-1984.
44. Alcacer J., Gittelman M., Sampat B. Applicant and examiner citations in US patents: an overview and analysis. Res Policy 2009, 38(2):415-427.
45. Michel J., Bettels B. Patent citation analysis: a closer look at the basic input data from patent search reports. Scientometrics 2001, 51(1):185-201.
46. Hall BH, Jaffe A, Trajtenberg M. The NBER patent citations data file: lessons, insights and methodological tools. NBER working paper series, vol. w8498, 2001. Available at SSRN: <>. http://ssrn.com/abstract=285618.
47. Schmoch U, Laville F, Patel P, Frietsch R. Linking technology areas to industrial sectors. Final report to the European Commission, DG Research. Karlsruhe: Fraunhofer ISI; 2003.
48. Harhoff D., Reitzig M. Determinants of opposition against EPO patent grants: the case of pharmaceuticals and biotechnology. Int J Indust Organiz 2004, 22:443-480.
49. ICIS Chemical Business, September 14-20, 2009. p. 18-20.
50. Annual reports of AkzoNobel, BASF, Bayer, Dow Chemical, DSM, Du Pont, Mitsubishi Chemical, Solvay, Sumitomo Chemical and Syngenta, 1999-2008.
51. Watanabe C., Tsuji Y.S., Griffy-Brown C. Patent statistics: deciphering a 'real' versus a 'pseudo' proxy of innovation. Technovation 2001, 21(12):783-790.
52. The Wall Street Journal, 23 June 2009.